Atsushi Higaki1, Akira Yamamoto1, Tsutomu Tamada1, Hiroki Higashi1, Tomohiro Sato1, Akihiko kanki1, Katsuyoshi Ito1
1Kawasaki Medical School, Kurashiki, Okayama, Japan
To evaluate the difference in enhancement effects of the liver between area of fatty change and area of non-fatty change at gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) enhanced MR imaging to clarify whether the presence of fatty infiltration affected the liver uptake of Gd-EOB-DTPA. Our results showed that the presence of fatty infiltration of the liver did not affect the hepatic contrast enhancement effects of Gd-EOB-DTPA in both vascular and hepatocellular phases. This fact indicated that the hepatic function for the uptake of Gd-EOB-DTPA can be preserved in the area of fatty change of the liver.